Central sleep apnea treatment in heart failure: Are we counting chickens before they are hatched?

Expert Review of Cardiovascular Therapy

Volumn 10, Issue 3, 2012, Pages 275-278

  Kourouklis, Spiros P ^a   Filippatos, Gerasimos ^b  

^a RED CROSS HOSPITAL   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

adaptive servoventilaton; central sleep apnea; CheyneStokes respiration; CPAP; CRT; heart failure; noninvasive ventilation

Indexed keywords

ACETAZOLAMIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; THEOPHYLLINE;

APNEA; ARTIFICIAL VENTILATION; CARDIAC RESYNCHRONIZATION THERAPY; CENTRAL SLEEP APNEA SYNDROME; CHEYNE STOKES BREATHING; DIAGNOSTIC PROCEDURE; HEART FAILURE; HEART OUTPUT; HEART TRANSPLANTATION; HUMAN; HYPOPNEA INDEX; MITRAL VALVE REPAIR; OXYGEN SATURATION; PATHOGENESIS; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PROGNOSIS; QUALITY OF LIFE; RESPIRATION CONTROL; REVIEW; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING; SLEEP QUALITY;

HEART FAILURE, SYSTOLIC; HUMANS; PROGNOSIS; SLEEP APNEA, CENTRAL;

EID: 84858205453     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.12.12     Document Type: Review

References (29)

1. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. J. Heart Fail. 10(10), 933-989 (2008).
2. Maggioni AP, Dahlström U, Filippatos G et al. EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot). Eur. J. Heart Fail. 12(10), 1076-1084 (2010).
3. Somers VK, White DP, Amin R et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. Circulation 118(10), 1080-1111 (2008).
4. Yumino D, Bradley TD. Central sleep apnea and Cheyne-Stokes respiration. Proc. Am. Thorac. Soc. 5, 226-236 (2008). (Pubitemid 351237882)
5. Yumino D, Redolfi S, Ruttanaumpawan P, et al. Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation 13, 121(14), 1598-1605 (2010).
6. Kuzniar TJ, Pusalavidyasagar S, Gay PC, et al. Natural course of complex sleep apnea: a retrospective study. Sleep Breath. 12, 135-139 (2008). (Pubitemid 351486674)
7. Tkacova R, Niroumand M, Lorenzi-Filho G, Bradley TD. Overnight shift from obstructive to central apneas in patients with heart failure: role of PCO2 and circulatory delay. Circulation 103, 238-243 (2001). (Pubitemid 32095409)
8. Ryan CM, Floras JS, Logan AG et al. Shift in sleep apnoea type in heart failure patients in the CANPAP trial. Eur. Respir. J. 35(3), 592-597 (2010).
9. Hagenah G, Zapf A, Schüttert JB. Cheyne-Stokes respiration and prognosis in modern-treated congestive heart failure. Lung 188(4), 309-313 (2010).
10. Vazir A, Morrell MJ, Hastings PC, McIntyre HF, Simonds AK, Cowie MR. Central sleep apnoea predicts mortality even in patients with mild chronic heart failure: a 6-year follow-up study. Heart 95, 88-92 (2009).
11. Yumino D, Wang H, Floras JS et al. Relationship between sleep apnoea and mortality in patients with ischaemic heart failure. Heart 95(10), 819-824 (2009).
12. Bitter T, Westerheide N, Prinz C, et al. Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. Eur. Respir. J. 32(1), 61-74 (2011).
13. Walsh JT, Andrews R, Starling R, Cowley AJ, Johnston ID, Kinnear WJ. Effects of captopril and oxygen on sleep apnoea in patients with mild to moderate congestive cardiac failure. BHJ 73(3), 237-241 (1991).
14. Tamura A, Kawano Y, Naono S, Kotoku M, Kadota J. Relationship between beta-blocker treatment and the severity of central sleep apnea in chronic heart failure. Chest 131, 130-135 (2007). (Pubitemid 46122984)
15. Rubin AE, Gottlieb SH, Gold AR et al. Elimination of central sleep apnoea by mitral valvuloplasty: the role of feedback delay in periodic breathing. Thorax 9, 174-176 (2004). (Pubitemid 38223490)
16. Yiu KH, Lee KL, Lau CP et al. Alleviation of pulmonary hypertension by cardiac resynchronization therapy is associated with improvement in central sleep apnea. Pacing Clin. Electrophysiol. 1(12), 1522-1527 (2008).
17. Lamba J, Simpson CS, Redfearn DP, Michael KA, Fitzpatrick M, Baranchuk A. Cardiac resynchronization therapy for the treatment of sleep apnoea: a meta-analysis. Europace 13(8), 1174-1179 (2011).
18. Sredniawa B, Lenarczyk R, Kowalski O et al. Sleep apnoea as a predictor of mid-and long-term outcome in patients undergoing cardiac resynchronization therapy. Europace 11(1), 106-114 (2009).
19. Collop NA. Cheyne-Stokes ventilation converting to obstructive sleep apnea following heart transplantation. Chest 104, 1288-1289 (1993). (Pubitemid 23306102)
20. Javaheri S. Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am. J. Respir. Crit. Care Med. 173, 234-237 (2003).
21. Javaheri S, Parker TJ, Wexler L, Liming JD, Lindower P, Roselle GA. Effect of theophylline on sleep-disordered breathing in heart failure. N. Engl. J. Med. 335, 562-567 (1996). (Pubitemid 26272311)
22. Sasayama S, Izumi T, Matsuzaki M et al.; CHF-HOT Study Group. Improvement of quality of life with nocturnal oxygen therapy in heart failure patients with central sleep apnea. Circ. J. 73(7), 1255-1262 (2009).
23. Lorenzi-Filho G, Rankin F, Bies I et al. Effects of inhaled carbon dioxide and oxygen on Cheyne-Stokes respiration in patients with heart failure. Am. J. Respir. Crit. Care Med. 159, 1490-1498 (1999). (Pubitemid 29227859)
24. Arzt M, Wensel R, Montalvan S et al. Effects of dynamic bilevel positive airway pressure support on central sleep apnea in men with heart failure. Chest 134(1), 1-66 (2008).
25. Bradley T, Logan A, Kimoff R et al. Continuous positive airway pressure for central sleep apnea and heart failure. N. Engl. J. Med. 353, 2025-2033 (2005). (Pubitemid 41609095)
26. Arzt M, Floras J, Logan A et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure. Circulation 115, 3173-3180 (2007).
27. Haruki N, Takeuchi M, Kaku K et al. Comparison of acute and chronic impact of adaptive servo-ventilation on left chamber geometry and function in patients with chronic heart failure. Eur. J. Heart Fail. 13(10), 1140-1146 (2011).
28. Kasai T, Usui Y, Yoshioka T et al.; JASV Investigators. Effect of flow-triggered adaptive servo-ventilation compared with continuous positive airway pressure in patients with chronic heart failure with coexisting obstructive sleep apnea and Cheyne-Stokes respiration. Circ. Heart Fail. 3(1), 140-148 (2010).
29. Koyama T, Watanabe H, Terada S et al. Adaptive servo-ventilation improves renal function in patients with heart failure. Respir. Med. 105(12), 1946-1953 (2011).